NDC Product
Human Prescription DrugOnpattro NDC 71336-1000
- Generic Name
- Patisiran
- Dosage Form
- Injection, Lipid Complex
- Route
- Intravenous
- Marketing
- NDA
Active Listing
PATISIRAN SODIUM
UNII WO0YM16LKG
Substance Identification & Data
This profile provides standardized clinical and technical data for Patisiran Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WO0YM16LKG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1386913-72-9 and the RxNorm Concept ID (RxCUI) 2053491. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
PATISIRAN SODIUM
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
WO0YM16LKG
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Patisiran Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
Common Names & Synonyms
PATISIRAN SODIUM
PATISIRAN SODIUM [JAN]
PATISIRAN SODIUM [MI]
PATISIRAN SODIUM [ORANGE BOOK]
PATISIRAN SODIUM [WHO-DD]
Brand / Trade Names
ONPATTRO
Systematic Nomenclature
RNA, (A-U-G-G-A-A-UM-A-C-U-C-U-U-G-G-U-UM-A-C-DT-DT), COMPLEX WITH RNA (G-UM-A-A-CM-CM-A-A-G-A-G-UM-A-UM-UM-CM-CM-A-UM-DT-DT), SODIUM SALT (1:1:40)
NDC Products Containing PATISIRAN SODIUM
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
